Many findings support a possible association between gastroesophageal reflux disease (GERD) and asthma in children, but there is not enough evidence to support the causality of this association. Longitudinal studies with long-term follow-up are urgently required to cover the many gaps that persist in this area. Treatment of GERD with proton pump inhibitors (PPIs) in children with uncontrolled asthma does not substantively improve asthma outcomes but large, controlled trials in children symptomatic of both asthma and GERD are lacking. Since there are significant safety concerns for long-term PPIs use in children, physicians should carefully balance their therapeutic decisions in individual cases.
Asthma, gastroesophageal reflux, comorbidity, microaspiration, pH measurement, proton pump inhibitors
Fernando Maria de Benedictis, Anna Maria Tocco and Giuliano Lombardi have nothing to disclose in relation to this article. No funding was received in the publication of this article.
Compliance with Ethics:This study involves a review of the literature and did not involve any studies with human or animal subjects performed by any of the authors.
Authorship: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published.
This article is published under the Creative Commons Attribution Noncommercial License, which permits any non-commercial use, distribution, adaptation and reproduction provided the original author(s) and source are given appropriate credit.
October 17, 2016 Accepted:
January 25, 2017
Fernando Maria de Benedictis, Salesi Children’s Hospital Foundation, 11, via Corridoni, I-60123 Ancona, Italy. E: email@example.com
Gastroesophageal reflux (GER), the intermittent ascent of acid contents into the oesophagus, is a normal physiological process. In contrast, gastroesophageal reflux disease (GERD) is present when the reflux of acid contents causes troublesome symptoms and/or complications.1 Asthma and symptomatic GER are both common disorders in childhood and symptoms of GER are frequently reported among children with asthma.2,3 Historically, respiratory manifestations have been recognized as a potential consequence of GERD, and the relationship between asthma and GERD has been largely debated in the literature.
The aim of this article is to critically review the nature and the clinical aspects of this association in childhood and shed light on one of the most controversial fields of respiratory medicine.
Exploring the association between asthma and gastroesophageal reflux disease
Over the last 30 years, several studies have evaluated the prevalence of GERD in children with asthma. Data are controversial, the differences in the reported prevalence being determined mainly by the criteria used for definition of GERD (that is, symptoms versus laboratory investigation), the asthmatic population included (mild versus severe asthma), the design of the study (interventional, cross-over, retrospective) and the presence of a control group. It is, therefore, not surprising that the mean prevalence of GERD in children with asthma varied from 19.6% to 62.9% when GERD was identified by gastrointestinal symptoms or oesophageal pH monitoring, respectively.4 Few studies included a control group, and the prevalence of GERD was 4.8% in healthy children. The pooled odds ratio for the association between GERD and asthma was 5.6 in controlled studies.4
Exploring the relationship between asthma and GERD in children is hampered by many shortcomings. A global, evidence-based consensus on the definition of GERD in the paediatric population suggests that GERD be defined by using a “patient-centred symptom-based” method.5 However, symptom-based criteria for GERD have significant limitations in children, because reporting of symptoms may be unreliable until the age of eight years.5 Furthermore, asthma and GERD may have similar symptoms in childhood, such as nocturnal cough, chest tightness and exercise-induced discomfort, thus making difficult to determine which children actually have GERD.6 Children and adolescents with GERD more commonly manifest cough and other respiratory symptoms than the typical oesophageal complaint of heartburn in adults.7,8 Indeed, in a recent study in children with poorly controlled asthma, no gastrointestinal symptom differentiated those with and without GER identified by oesophageal pH monitoring.9 Taken together, these findings emphasise that the prevalence of GERD in asthmatic children identified in studies that used symptom scores as inclusion criteria and/or endpoints is likely biased by the inability to differentiate symptoms of asthma from those of GER.
The majority of studies that examined GERD in children with asthma reported oesophageal pH measurement. However, these studies often selected a reflux-index threshold that was lower than that required by evidence-based guidelines, which possibly led to an overestimation of the prevalence of reflux in patients with asthma. On the other hand, pH-metry is limited by the inherent inability to detect non-acid reflux.
From a clinical point of view, the temporal interdependence between GERD and asthma is an important proof of concept for a causal relationship. This aspect was investigated in three cross-sectional studies that assessed whether respiratory symptoms (wheezing, cough) followed episodes of GERD.10,11,12 These studies failed to show a consistent relationship between respiratory symptoms and periods of abnormal oesophageal pH or reflux symptoms, thus underlying that the association of GERD and asthma cannot necessarily be causal, but is rather due to chance alone.
The pathophysiological relationship between asthma and GER has gained much attention by pulmonologists, gastroenterologists and physiologists over the years. The available evidence does not yet clearly indicate whether GER precedes and/or triggers asthma, or asthma precedes and/ or triggers GER. It is, however, likely that each one of these conditions may act as aggravating cofactor of the other.
There are several anatomic and physiological reasons that can justify the increased prevalence of GERD in asthmatic patients. Asthma is known to promote GER by different mechanisms including:
• airway obstruction with concomitant increase of negative intrathoracic pressure, that increases the pressure gradient across the lower oesophageal sphincter;
• cough-induced increase in intra-abdominal pressure, that in turn augments the gastroesophageal pressure gradient;
• lung hyperinflation, that may alter the anatomic connection of the gastroesophageal junction through the crural diaphragm; and
• asthma medications (such as beta2-agonists, aminophylline) that may induce relaxation of the lower oesophageal sphincter.13
On the other hand, two major pathophysiological mechanisms, which are not mutually exclusive, have been proposed to explain how GER may exacerbate asthma:
• microaspiration of gastric content can cause tissue injury of the airway and local inflammation (aspiration theory); and/or
• stimulation of pH-sensitive irritant receptors in the distal oesophagus may both elicit bronchospasm and increase airway hyperresponsiveness through cholinergic pathways (reflex theory).
In addition, neuroinflammatory reflexes may be involved through the release of tachykinins and other neurotransmitters in the airway by nociceptive afferent nerves, thus resulting in airway oedema, mucus secretion, vasodilation and bronchial constriction.14
Patients with GER have significantly reduced laryngopharyngeal sensitivity because of repeated exposure of mucosa to small amounts of acid, thus increasing the risk for aspiration. Chronic microaspiration of refluxate into the airway may present with chronic cough, wheeze and recurrent episodes of pneumonia, and may result in progressive lung disease. However, there is no gold standard test for diagnosing chronic lung aspiration, and determining whether aspiration is a significant cause of respiratory disease remains a challenge in paediatric medicine.15
1. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. ,Pediatric
gastroesophageal reflux clinical practice guidelines: joint
recommendations of the North American Society for Pediatric
Gastroenterology, Hepatology, and Nutrition (NASPGHAN)
and the European Society for Pediatric Gastroenterology,
Hepatology, and Nutrition (ESPGHAN),J Pediatr Gastroenterol
2. Field SK, Underwood M, Brant R, et al., Prevalence of
gastroesophageal symptoms in asthma, Chest, 1996;109:316–22.
3. Hancox RJ, Poulton R, Taylor DR, et al., Associations between
respiratory symptoms, lung function and gastrooesophageal
reflux symptoms in a population-based birth cohort, Respir
4. Thakkar K, Boatright RO, Gilger MA, et al., Gastroesophageal
reflux and asthma in children: a systematic review, Pediatrics,
5. Sherman PM, Hassall E, Fagundes-Neto U, et al., A
global, evidence-based consensus on the definition of
gastroesophageal reflux disease in the pediatric population,
Am J Gastroenterol, 2009;104:1278–95.
6. Blake K, Teague WG, Gastroesophageal reflux disease and
childhood asthma, Curr Opin Pulm Med, 2013;19:24–9.
7. El-Serag HB, Gilger M, Kuebeler M, et al., Extraesophageal
associations of gastroesophageal reflux disease in children
without neurologic defects, Gastroenterology, 2001;121:1294–9.
8. Andze GO, Brandt ML, St Vil D, et al., Diagnosis and treatment
of gastroesophageal reflux in 500 children with respiratory
symptoms: The value of pH monitoring, J Pediatr Surg,
9. Holbrook JT, Wise RA, Gold BD, et al., Lansoprazole for children
with poorly controlled asthma: a randomized clinical trial,
10. Martin ME, Grunstein MM, Larsen GL, The relationship of
gastroesophageal reflux to nocturnal wheezing in children with
asthma, Ann Allergy, 1982;49:318–22.
11. Gustafsson PM, Kjellman NI, Tibbling L, Bronchial asthma and
acid reflux into the distal and proximal oesophagus, Arch Dis
12. Cinquetti M, Micelli S, Voltolina C, et al., The pattern of
gastroesophageal reflux in asthmatic children, J Asthma,
13. Parsons JP, Mastronarde JG, Gastroesophageal reflux disease
and asthma, Curr Opin Pulm Med, 2010; 16:60–3.
14. Harding SM, Richter JE, The role of gastroesophageal reflux in
chronic cough and asthma, Chest, 1997;111:1389–402.
15. de Benedictis FM, Carnielli V, de Benedictis D, Aspiration lung
syndrome, Pediatr Clin North Am, 2009;56:173–90.
16. Asher MI, Montefort S, Bijorksten B, et al., Worldwide time
trends in the prevalence of symptoms of asthma, allergic
rhinoconjunctivitis, and eczema in childhood: ISAAC Phases
One and Three repeat multicountry cross-sectional surveys,
17. Dent J, El-Serag HB, Wallender MA, et al., Epidemiology of
gastro-esophageal reflux disease: a systematic review, Gut,
18. de Benedictis FM, Bush A, Problematic severe asthma in
children: the Pandora’ box, Eur Respir Dis, 2011;7:91–6.
19. Gibson PG, Henry RL, Coughlan JL, Gastro-oesophageal
reflux treatment for asthma in adults and children, Cochrane
Database Syst Rev, 2003;2:CD001496.
20. Kiljander TO, Harding SM, Field SK, et al., Effects of
esomeprazole 40 mg twice daily on asthma: a randomized
placebo-controlled trial, Am J Respir Crit Care Med,
21. Mastronarde JG, Anthonisen NR, Castro M, et al., Efficacy of
esomeprazole for treatment of poorly controlled asthma,
N Engl J Med, 2009;360:1487–99.
22. Stordal K, Johannesdottir GB, Bentsen BS, et al., Acid
suppression does not change respiratory symptoms in children
with asthma and gastro-oesophageal reflux disease, Arch Dis
23. Fitzpatrick AM, Holbrook JT, Wei CY, et al., Exhaled breath
condensate pH does not discriminate asymptomatic
gastroesophageal reflux or the response to lansoprazole
treatment in children with poorly controlled asthma, J Allergy
Clin Immunol Pract, 2014;2:579–86.
24. Condino AA, Sondheimer J, Pan Z, et al., Evaluation of
gastroesophageal reflux in pediatric patients with
asthma using impedance-pH monitoring, J Pediatr,
25. Kiljander TO, Junghard O, Beckman O, Lind T, Effect of
esomeprazole 40 mg once or twice daily on asthma: a
randomized, placebo-controlled study, Am J Respir Crit Care
26. Vela MF, Camacho-Lobato L, Srinivasan R, et al., Simultaneous
intraesophageal impedance and pH measurement of acid
and nonacid gastroesophageal reflux: effect of omeprazole,
27. Rantanen T, Kiljander T, Salminen P, et al. Reflux symptoms
and side effects among patients with gastroesophageal
reflux disease at baseline, during treatment with PPIs,
and after Nissen fundoplication, World J Surg,
28. Mattioli G, Sacco O, Repetto P, et al., Necessity for surgery in
children with gastrooesophageal reflux and supraoesophageal
symptoms, Eur J Pediatr Surg, 2004;14:7–13.
29. Deal L, Gold BD, Gremse DA, et al., Age-specific questionnaires
distinguish GERD symptom frequency and severity in infants
and young children: development and initial validation,
J Pediatr Gastroenterol Nutr, 2005;41:178–85.
30. Nelson SP, Chen EH, Syniar GM, et al., Prevalence of symptoms
of gastroesophageal reflux during childhood: a pediatric
practice-based survey. Pediatric Practice Research Group,
Arch Pediatr Adolesc Med, 2000;154:150–4.
31. Lambert AA, Lam JO, Paik JJ, et al., Risk of communityacquired
pneumonia with outpatient proton-pump inhibitor
therapy: a systematic review and meta-analysis, PLoS One,
32. Lau AN, Tomizza M, Wong-Pack M, et al., The relationship
between long-term proton pump inhibitor therapy and skeletal
frailty, Endocrine, 2015;49:606–10.
33. Martinez FD, Children, asthma, and proton pump
inhibitors: costs and perils of therapeutic creep, JAMA,